You are here: Industry Insights > COVID-19 Vaccine

News List

UK’s MHRA starts rolling review of Moderna’s COVID-19 vaccine pharmatimes
October 29, 2020
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has begun the rolling review process of Moderna’s COVID-19 vaccine candidate, mRNA-1273.
Sanofi, GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine americanpharmaceuticalreview
October 29, 2020
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.
Japan’s cabinet approves plan for free COVID-19 vaccines expresspharma
October 29, 2020
Japan’s cabinet approved a plan on Tuesday to use public funds to provide novel coronavirus vaccines to the public for free.
PMI announces Medicago to supply up to 76 mn doses of its plant-derived COVID-19 vaccine candidate expresspharma
October 29, 2020
Medicago began the phase I testing on volunteers on July 14 and is anticipating that phase II trials will begin in early November 2020.
Australia’s star vaccine maker not immune to virus anxiety: Analysis expresspharma
October 29, 2020
A promise to supply Australia's 25 million people with a coronavirus vaccine, if one becomes available, has boosted CSL's profile.
Moderna signs Covid-19 vaccine supply deal with Qatar pharmaceutical-technology
October 29, 2020
Moderna has signed a supply agreement with the Ministry of Public Health of Qatar for its Covid-19 vaccine candidate, mRNA-1273.
AstraZeneca resumes US phase III COVID-19 vaccine trial pharmatimes
October 29, 2020
AstraZeneca has resumed all clinical trials of its coronavirus vaccine candidate after the Food and Drug Administration (FDA) authorised the restart in the US.
Novavax provides Phase 3 COVID-19 vaccine clinical development update worldpharmanews
October 29, 2020
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19 vaccine candidate.
Russia applies for WHO emergency use tag for its COVID-19 vaccine expresspharma
October 28, 2020
The procedures would allow Sputnik V to be included in the list of medical products that meet leading quality.
AstraZeneca gets FDA approval to restart Phase III Covid-19 vaccine trial pharmaceutical-technology
October 28, 2020
The US Food and Drug Administration (FDA) has authorised the restart of Phase III clinical trial of AstraZeneca and Oxford University’s Covid-19 vaccine candidate, AZD1222, in the country.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page